Skip to main content

Table 1 Clinical pathological data of AGC patients with synchronous liver metastasis

From: Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study

Clinical pathological data Group underwent adjuvant gastrectomy Group treated with chemotherapy only P value
Age 61.4 ± 9.5 60.8 ± 7.9 0.834
BSA 1.758 ± 0.186 1.743 ± 0.142 0.755
Gender (male vs. female) 3.2:1 5:1 0.725
Primary tumor location    0.003
EGJ 4 (16.7 %) 0 (0 %)  
U 2 (8.3 %) 9 (42.9 %)  
M 3 (12.5 %) 5 (23.8 %)  
L 15 (62.5 %) 7 (33.3 %)  
Borrmann type    0.355
I 0 (0 %) 0 (0 %)  
II 3 (13.6 %) 4 (21.1 %)  
III 19 (86.4 %) 14 (73.7 %)  
IV 0 (0 %) 1 (5.3 %)  
Histological grade    0.594
Low differentiation 9 (40.9 %) 9 (45.0 %)  
Median and low differentiation 0 (0 %) 1 (5.0 %)  
Median differentiation 4 (18.2 %) 4 (20.0 %)  
High and median differentiation 9 (40.9 %) 6 (30.0 %)  
Pathological classification    0.273
Adenocarcinoma 22 (91.7 %) 21 (100 %)  
Small cell carcinoma 1 (4.2 %) 0 (0 %)  
Signet ring cell carcinoma 1 (4.2 %) 0 (0 %)  
T stage (TNM version 7)    0.387
T2 3 (13.0 %) 1 (5.0 %)  
T3 1 (4.3 %) 0 (0 %)  
T4a 17 (73.9 %) 15 (75.0 %)  
T4b 2 (8.7 %) 4 (20.0 %)